By Marisa Moura Momoli
February 14, 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.
Last by Marisa Moura Momoli
September 9, 2024
Kasznar Leonardos wins LMG Life Sciences
We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! … Kasznar Leonardos wins LMG Life Sciences
July 11, 2024
Marisa Momoli stands out in ABAPI’s patent course
Our biologist Marisa Momoli taught the advanced patent course at ABAPI on July 8th. The lecture, entitled “Plant Varieties and Patents, definitions, … Marisa Momoli stands out in ABAPI’s patent course
May 24, 2024
New WIPO Treaty on Genetic Resources and Associated Traditional Knowledge Approved
Member states of the World Intellectual Property Organization (WIPO) have approved a groundbreaking treaty that addresses the intersection between intellectual property, more … New WIPO Treaty on Genetic Resources and Associated Traditional Knowledge Approved